In the context of breast cancer treatment, relapse is a common concern that can be addressed with proactive
measures to assess the risk of recurrence.
Leveraging the insights provided by precision
medicine, medical oncologists will be better equipped to formulate personalized treatment strategies. The
aim is to mitigate the risk of relapse and reduce the uncertainty that often accompanies a health journey,
allowing patients to live a life less burdened by medical concerns.
Knowledge can bring certainty and comfort to patients as they gain a better understanding of their disease, treatment, and outlook, ultimately improving their quality of life by ruling out the uncertainties they face.
for Patients
Why is it important to characterize MAF amplification in your breast cancer tumor?
The presence of MAF gene amplification, which is the case in 20% of the patients with breast cancer tumors, is associated with the risk of relapse. Being MAF positive tells how aggressively the breast cancer tumor behaves. This knowledge, together with other clinical and pathological data is essential to understand the progression of the breast cancer tumor. This provides patients a perspective to get the most effective and personalised care to fight the cancer.
What is the MAF Test®
MAF Test®
is a laboratory analysis that the pathologist performs to characterize the breast tumor and
establishes the risk of progression of your disease.
MAF Test®
measures the amplification of the MAF gene in your tumor. MAF amplification occurs in 20% of breast
cancer tumors and it is associated with a higher risk of progression of the disease.
Perspectives
With more accurate information, oncologists can provide patients the knowledge to explore treatment plans with better prognoses to avoid relapse, allowing them to live with greater clarity.
Patients
With this new insight, oncologists will gain a valuable tool to add to their arsenal, having the power to make a difference in the lives of their patients.
With the MAF Test®, pathologists can provide better insights to support informed decisions. Contributing to help delivering optimal treatments that fit each patient's unique needs.
Together, we will drive new perspectives towards a future where breast cancer is no longer a life-threatening disease.
